Biotronik SE & Co. KG:企業の製品パイプライン分析2016

GlobalDataが発行した調査報告書(GDME818PD)
◆英語タイトル:Biotronik SE & Co. KG - Product Pipeline Analysis, 2016 Update
◆商品コード:GDME818PD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年2月3日
◆ページ数:55
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary

Biotronik SE & Co. KG (Biotronik) develops, manufactures and distributes cardio and endovascular medical devices. The company offers cardiac rhythm therapy solutions, electrophysiology products and vascular intervention products. Its technologies include Home Monitoring, ProMRI, DX Atrial Sensing, Closed Loop Stimulation, AlCath Flux eXtra Gold and others. Biotronik’ products are used in various areas including bradycardia therapy, tachyarrhythmia therapy, electrophysiology, cardiac resynchronization, Coronary vascular intervention, peripheral vascular intervention. It has manufacturing facilities in Germany, Switzerland and the US. The company markets its products through a network of sales force across Europe, North America, Latin America, Asia, Oceania and Africa. Biotronik is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biotronik SE & Co. KG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Biotronik SE & Co. KG Company Snapshot 7
Biotronik SE & Co. KG Company Overview 7
Key Information 8
Biotronik SE & Co. KG Pipeline Products and Clinical Trials Overview 9
Biotronik SE & Co. KG – Pipeline Analysis Overview 11
Business Description 11
Biotronik SE & Co. KG – Major Products and Services 12
Biotronik SE & Co. KG Pipeline Products by Development Stage 13
Biotronik SE & Co. KG Clinical Trials by Trial Status 15
Biotronik SE & Co. KG Pipeline Products Overview 18
AMS-1 18
AMS-1 Product Overview 18
AMS-2 19
AMS-2 Product Overview 19
Astron Peripheral Vascular Stent 20
Astron Peripheral Vascular Stent Product Overview 20
Astron Peripheral Vascular Stent Clinical Trial 21
Astron Pulsar Self Expanding Peripheral Stent 22
Astron Pulsar Self Expanding Peripheral Stent Product Overview 22
Astron Pulsar Self Expanding Peripheral Stent Clinical Trial 23
DREAMS 24
DREAMS Product Overview 24
DREAMS 2 25
DREAMS 2 Product Overview 25
DREAMS 2 Clinical Trial 26
Orsiro Hybrid Drug Eluting Stent 27
Orsiro Hybrid Drug Eluting Stent Product Overview 27
Orsiro Hybrid Drug Eluting Stent Clinical Trial 28
ProGenic Pimecrolimus-eluting Coronary Stent System 31
ProGenic Pimecrolimus-eluting Coronary Stent System Product Overview 31
ProMRI Iforia 5 HF-T ICD 32
ProMRI Iforia 5 HF-T ICD Product Overview 32
ProMRI Iforia 5 Series DR-T ICD 33
ProMRI Iforia 5 Series DR-T ICD Product Overview 33
ProMRI Iforia 5 Series DR-T ICD Clinical Trial 34
ProMRI Iforia 5 VR-T DX ICD 35
ProMRI Iforia 5 VR-T DX ICD Product Overview 35
ProMRI Iforia 5 VR-T ICD 36
ProMRI Iforia 5 VR-T ICD Product Overview 36
ProMRI Iforia 7 DR-T ICD 37
ProMRI Iforia 7 DR-T ICD Product Overview 37
ProMRI Iforia 7 HF-T ICD 38
ProMRI Iforia 7 HF-T ICD Product Overview 38
ProMRI Iforia 7 VR-T DX ICD 39
ProMRI Iforia 7 VR-T DX ICD Product Overview 39
ProMRI Iforia 7 VR-T ICD 40
ProMRI Iforia 7 VR-T ICD Product Overview 40
Pulsar-18 Self Expanding Stent 41
Pulsar-18 Self Expanding Stent Product Overview 41
Biotronik SE & Co. KG – Key Competitors 42
Biotronik SE & Co. KG – Key Employees 43
Biotronik SE & Co. KG – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 46
Biotronik SE & Co. KG, Recent Developments 46
Feb 01, 2016: BIOTRONIK Announces CE Approval for new series of ICDs and CRT-Ds with MRI AutoDetect 46
Jan 26, 2016: BIOTRONIK Announces Expansion Of Passeo-18 Lux Drug-Coated Balloon Portfolio 46
Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 47
Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 48
Dec 10, 2015: BIOTRONIK Announces Start of New Study Evaluating whether Pacemakers with Closed Loop Stimulation Prevent Reflex Syncope 49
Dec 04, 2015: BIOTRONIK and Cardiology Experts Support Heartbeat International in Top Education 50
Dec 02, 2015: BIOTRONIK and Heartbeat International Foundation Conclude Milestone Year by Opening Heart Center in the Dominican Republic 50
Dec 01, 2015: BIOTRONIK Announces Start of Study to Evaluate Benefits of Unique Rate Response Algorithm for Atrial Fibrillation Patients 51
Dec 01, 2015: World’s Only Company to Offer Japan’s ICD and Pacemaker Patients 3 Tesla MRI Access 51
Nov 20, 2015: BIOTRONIK Announces Improved Patient Outcomes with Innovative “Combination Therapy” for Peripheral Artery Disease 52
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 55
Disclaimer 55

List of Tables
Biotronik SE & Co. KG, Key Facts 8
Biotronik SE & Co. KG Pipeline Products and Clinical Trials Overview 9
Biotronik SE & Co. KG Pipeline Products by Equipment Type 9
Biotronik SE & Co. KG Pipeline Products by Indication 10
Biotronik SE & Co. KG Clinical Trials by Trial Status 10
Biotronik SE & Co. KG, Major Products and Services 12
Biotronik SE & Co. KG Number of Pipeline Products by Development Stage 13
Biotronik SE & Co. KG Pipeline Products Summary by Development Stage 14
Biotronik SE & Co. KG Clinical Trials by Trial Status 15
Biotronik SE & Co. KG Clinical Trials Summary 16
AMS-1 - Product Status 18
AMS-1 - Product Description 18
AMS-2 - Product Status 19
AMS-2 - Product Description 19
Astron Peripheral Vascular Stent - Product Status 20
Astron Peripheral Vascular Stent - Product Description 20
Astron Peripheral Vascular Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents 21
Astron Pulsar Self Expanding Peripheral Stent - Product Status 22
Astron Pulsar Self Expanding Peripheral Stent - Product Description 22
Astron Pulsar Self Expanding Peripheral Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents 23
Astron Pulsar Self Expanding Peripheral Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe) 23
DREAMS - Product Status 24
DREAMS - Product Description 24
DREAMS 2 - Product Status 25
DREAMS 2 - Product Description 25
DREAMS 2 - BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOSOLVE-II 26
Orsiro Hybrid Drug Eluting Stent - Product Status 27
Orsiro Hybrid Drug Eluting Stent - Product Description 27
Orsiro Hybrid Drug Eluting Stent - A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-eluting Stent with a Durable Polymer Everolimus-eluting Stent for Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention 28
Orsiro Hybrid Drug Eluting Stent - BIOFLOW-VI Clinical Study in China 28
Orsiro Hybrid Drug Eluting Stent - Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX): A Randomized Trial with Stent Evaluation in All-comers IV (TWENTE IV) 28
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects with up to Three De Novo or Restenotic Coronary Artery Lesions - V 28
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - Safety and Performance Registry for an All-comers Patient Population with the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III French Satellite 29
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - Safety and Performance Registry for an All-comers Patient Population with the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III United Kingdom Satellite 29
Orsiro Hybrid Drug Eluting Stent - Harmonized Optimal Strategy to Treat Coronary Artery Disease - Coronary Intervention with Next Generation Drug-eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy Trial (HOST-IDEA) 29
Orsiro Hybrid Drug Eluting Stent - Randomized Comparison of a Polymer-free Biolimus-eluting BioFreedom Stent with a Biodegradable-polymer Sirolimus-eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention 30
Orsiro Hybrid Drug Eluting Stent - The Comparison of Strategies to PREPARE Severely CalCified Coronary Lesions Trial (PREPARE-CALC): A Prospective Randomized Controlled Trial of Rotational Atherectomy Versus Cutting/Scoring Balloon in Severely Calcified Coronary Lesions 30
ProGenic Pimecrolimus-eluting Coronary Stent System - Product Status 31
ProGenic Pimecrolimus-eluting Coronary Stent System - Product Description 31
ProMRI Iforia 5 HF-T ICD - Product Status 32
ProMRI Iforia 5 HF-T ICD - Product Description 32
ProMRI Iforia 5 Series DR-T ICD - Product Status 33
ProMRI Iforia 5 Series DR-T ICD - Product Description 33
ProMRI Iforia 5 Series DR-T ICD - ProMRI 3T ENHANCED Master Study 34
ProMRI Iforia 5 VR-T DX ICD - Product Status 35
ProMRI Iforia 5 VR-T DX ICD - Product Description 35
ProMRI Iforia 5 VR-T ICD - Product Status 36
ProMRI Iforia 5 VR-T ICD - Product Description 36
ProMRI Iforia 7 DR-T ICD - Product Status 37
ProMRI Iforia 7 DR-T ICD - Product Description 37
ProMRI Iforia 7 HF-T ICD - Product Status 38
ProMRI Iforia 7 HF-T ICD - Product Description 38
ProMRI Iforia 7 VR-T DX ICD - Product Status 39
ProMRI Iforia 7 VR-T DX ICD - Product Description 39
ProMRI Iforia 7 VR-T ICD - Product Status 40
ProMRI Iforia 7 VR-T ICD - Product Description 40
Pulsar-18 Self Expanding Stent - Product Status 41
Pulsar-18 Self Expanding Stent - Product Description 41
Biotronik SE & Co. KG, Key Employees 43
Biotronik SE & Co. KG, Subsidiaries 44

List of Figures
Biotronik SE & Co. KG Pipeline Products by Equipment Type 10
Biotronik SE & Co. KG Pipeline Products by Development Stage 13
Biotronik SE & Co. KG Clinical Trials by Trial Status 15

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Biotronik SE & Co. KG:企業の製品パイプライン分析2016(Biotronik SE & Co. KG - Product Pipeline Analysis, 2016 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆